Smoking Cessation Intervention for Persons Infected With Hepatitis C Virus
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Change in the number of cigarettes smoked per day (CPD)
研究概览
简要总结
A 12-week study for patients who are being treated for Hepatitis C and would like to quit smoking. During the 12 weeks of Hepatitis C treatment, the research team will have counseling sessions with the participants to discuss challenges related to Hepatitis C and smoking.
详细描述
A 12-week smoking cessation intervention addressing concurrently HCV and smoking cessation The Standard of care for HCV is 12 weeks of oral medication with 3 in-person provider/laboratory visits throughout. This study utilizes both in-person and phone counseling and health education sessions. Each session will address a different topic related to HCV, smoking, and how both smoking and HCV affect health and quality of life.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults (≥18 years old)
- •Current HCV infection (HCV RNA+)
- •Current cigarette smoking
- •Patients in contemplation / preparation stage of change
排除标准
- •Inability to speak/read English, as materials will be provided in English
- •Current suicidal ideation as determined by the PHQ-9, requiring a greater level of clinical care
- •Severe medical or psychiatric disability that prevents participant from ability to comprehend or consent to study
研究组 & 干预措施
Current smokers with an HCV infection
Persons who currently smoke cigarettes and are also HCV RNA+
干预措施: Cognitive Behavioral Counseling (Behavioral)
结局指标
主要结局
Change in the number of cigarettes smoked per day (CPD)
时间窗: baseline (week 0) to end of treatment (week 12)
We will track the number of cigarettes the participant smokes per day at each weekly visit, then compare the CPD at baseline during week 0 to the end of treatment at week 12.
Change in Fagerstrom Test for Nicotine Dependence (FTND) score
时间窗: baseline (week 0) to end of treatment (week 12)
We will calculate the participant's FTND score at the baseline visit during week 0 and compare it to their FTND score at the end of treatment visit during week 12.
次要结局
- Change in depressive symptomology using Patient Health Questionnaire (PHQ-9) score(baseline (week 0) to end of treatment (week 12))
- Number of quit attempts(baseline (week 0) to end of treatment (week 12))
